BRPI0909164A2 - método e composições para o tratamento de câncer - Google Patents

método e composições para o tratamento de câncer

Info

Publication number: BRPI0909164A2
Authority: BR; Brazil
Prior art keywords: compositions; cancer treatment; cancer; treatment
Prior art date: 2008-03-27

Application number

BRPI0909164A

Other languages

English (en)

Inventor

Angelika Burger

Bernardus Rademaker

Hans Hendriks

Original Assignee

Komipharm Int Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-27

Filing date

2009-03-24

Publication date

2016-06-21

2009-03-24 Application filed by Komipharm Int Co Ltd filed Critical Komipharm Int Co Ltd

2016-06-21 Publication of BRPI0909164A2 publication Critical patent/BRPI0909164A2/pt

Links

206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0909164A 2008-03-27 2009-03-24 método e composições para o tratamento de câncer BRPI0909164A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US3998708P	2008-03-27	2008-03-27
US12/408,864 US20090246291A1 (en)	2008-03-27	2009-03-23	Method and compositions for treatment of cancer
PCT/US2009/038104 WO2009120697A2 (en)	2008-03-27	2009-03-24	Method and compositions for treatment of cancer

Publications (1)

Publication Number	Publication Date
BRPI0909164A2 true BRPI0909164A2 (pt)	2016-06-21

Family

ID=41114644

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909164A BRPI0909164A2 (pt)	2008-03-27	2009-03-24	método e composições para o tratamento de câncer

Country Status (20)

Country	Link
US (2)	US20090246291A1 (pt)
EP (1)	EP2268292B1 (pt)
JP (2)	JP5543956B2 (pt)
KR (1)	KR101634138B1 (pt)
CN (2)	CN102046187A (pt)
AU (1)	AU2009228378B2 (pt)
BR (1)	BRPI0909164A2 (pt)
CA (1)	CA2719766C (pt)
CY (1)	CY1120536T1 (pt)
DK (1)	DK2268292T3 (pt)
ES (1)	ES2656762T3 (pt)
HU (1)	HUE036609T2 (pt)
LT (1)	LT2268292T (pt)
MX (1)	MX2010010621A (pt)
PL (1)	PL2268292T3 (pt)
PT (1)	PT2268292T (pt)
RU (1)	RU2508116C2 (pt)
SI (1)	SI2268292T1 (pt)
WO (1)	WO2009120697A2 (pt)
ZA (1)	ZA201006988B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1721615A1 (en)	2005-05-09	2006-11-15	Komipharm International Co., Ltd.	Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US9447049B2 (en)	2010-03-01	2016-09-20	University Of Tennessee Research Foundation	Compounds for treatment of cancer
SI2475362T1 (sl) *	2009-09-10	2019-08-30	Kominox, Inc.	Terapija proti raku, ciljana na rakave matične celice in odporna proti zdravilom
US8795738B2 (en) *	2009-11-12	2014-08-05	Board Of Regents Of The University Of Texas System	Use of arsenic for cancer therapy protection
US11084811B2 (en)	2010-03-01	2021-08-10	Oncternal Therapeutics, Inc.	Compounds for treatment of cancer
KR101783190B1 (ko) *	2010-07-18	2017-09-29	니키 파머 액퀴지션 코포레이션 2	루테늄 착체를 사용하는 병용 치료요법
CA2809256C (en) *	2010-08-24	2019-03-05	Gtx, Inc.	Compounds for treatment of cancer
WO2012131487A2 (en) *	2011-03-30	2012-10-04	Kominox, Inc.	Compositions and methods for the treatment of cancer
US8834938B2 (en)	2011-05-18	2014-09-16	Board Of Regents Of The University Of Texas System	Use of arsenic for cancer therapy protection
EP2707008A4 (en) *	2011-05-12	2014-11-26	Univ Texas	USE OF ARSEN FOR CANCER THERAPY PROTECTION
WO2014152330A1 (en) *	2013-03-15	2014-09-25	Stc.Unm	Arsenic-based treatment of cancers and inflammatory disorders
KR101309844B1 (ko)	2013-03-15	2013-09-23	박상채	항암 활성 증진용 한약재 및 이의 제조방법
WO2015009888A2 (en) *	2013-07-19	2015-01-22	Onyx Therapeutics, Inc.	Peptide epoxyketone proteasome inhibitors in combination with pim kinase inhibitors for treatment of cancers
CN109952105A (zh)	2016-12-01	2019-06-28	尤法玛私人有限公司	含砷组合物
JP7419333B2 (ja) *	2018-03-22	2024-01-22	コミファームインターナショナルオーストラリアピーティーワイリミテッド	メタ亜ヒ酸塩を含む医薬組成物および製造方法
CN116236505A (zh) *	2023-03-15	2023-06-09	上海市第四人民医院	三氧化二砷在制备肺神经内分泌癌治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1391206T3 (da) *	1997-10-15	2008-09-01	Polarx Biopharmaceuticals Inc	Farmaceutiske præparater der omfatter arsentrioxyd til behandling af ikke-Hodgkins lymfom
CA2309652C (en) *	1997-11-10	2013-01-29	Memorial Sloan-Kettering Cancer Center	Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
KR20020083678A (ko) *	2001-04-28	2002-11-04	주식회사 한국미생물연구소	아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
PT1496918T (pt) *	2002-04-10	2023-05-25	Komipharm Int Co Ltd	Utilização de meta-arsenito de sódio para o tratamento de tumores
EP1721615A1 (en) *	2005-05-09	2006-11-15	Komipharm International Co., Ltd.	Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8097237B2 (en) *	2005-08-23	2012-01-17	Stc.Unm	Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
WO2009049258A1 (en) *	2007-10-12	2009-04-16	The Johns Hopkins University	Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies

2009
- 2009-03-23 US US12/408,864 patent/US20090246291A1/en not_active Abandoned
- 2009-03-24 RU RU2010143893/15A patent/RU2508116C2/ru active
- 2009-03-24 CA CA2719766A patent/CA2719766C/en active Active
- 2009-03-24 KR KR1020107024132A patent/KR101634138B1/ko active Active
- 2009-03-24 ES ES09723788.7T patent/ES2656762T3/es active Active
- 2009-03-24 AU AU2009228378A patent/AU2009228378B2/en not_active Ceased
- 2009-03-24 DK DK09723788.7T patent/DK2268292T3/en active
- 2009-03-24 CN CN2009801187686A patent/CN102046187A/zh active Pending
- 2009-03-24 LT LTEP09723788.7T patent/LT2268292T/lt unknown
- 2009-03-24 EP EP09723788.7A patent/EP2268292B1/en active Active
- 2009-03-24 WO PCT/US2009/038104 patent/WO2009120697A2/en not_active Ceased
- 2009-03-24 JP JP2011501983A patent/JP5543956B2/ja not_active Expired - Fee Related
- 2009-03-24 BR BRPI0909164A patent/BRPI0909164A2/pt not_active Application Discontinuation
- 2009-03-24 PL PL09723788T patent/PL2268292T3/pl unknown
- 2009-03-24 HU HUE09723788A patent/HUE036609T2/hu unknown
- 2009-03-24 MX MX2010010621A patent/MX2010010621A/es active IP Right Grant
- 2009-03-24 PT PT97237887T patent/PT2268292T/pt unknown
- 2009-03-24 CN CN201510355863.5A patent/CN104997808A/zh active Pending
- 2009-03-24 SI SI200931809T patent/SI2268292T1/en unknown
2010
- 2010-09-30 ZA ZA2010/06988A patent/ZA201006988B/en unknown
2014
- 2014-03-10 JP JP2014046212A patent/JP2014101387A/ja not_active Withdrawn
2017
- 2017-06-02 US US15/613,020 patent/US20180055812A1/en not_active Abandoned
2018
- 2018-03-09 CY CY20181100285T patent/CY1120536T1/el unknown

Also Published As

Publication number	Publication date
DK2268292T3 (en)	2018-03-12
LT2268292T (lt)	2018-03-26
EP2268292A4 (en)	2011-05-11
HUE036609T2 (hu)	2018-07-30
JP2014101387A (ja)	2014-06-05
CY1120536T1 (el)	2019-07-10
CN102046187A (zh)	2011-05-04
AU2009228378B2 (en)	2014-07-17
KR20110009664A (ko)	2011-01-28
CN104997808A (zh)	2015-10-28
AU2009228378A1 (en)	2009-10-01
RU2010143893A (ru)	2012-05-10
PL2268292T3 (pl)	2018-06-29
ES2656762T3 (es)	2018-02-28
KR101634138B1 (ko)	2016-06-28
ZA201006988B (en)	2012-05-30
SI2268292T1 (en)	2018-03-30
JP2011515481A (ja)	2011-05-19
US20180055812A1 (en)	2018-03-01
WO2009120697A2 (en)	2009-10-01
EP2268292A2 (en)	2011-01-05
JP5543956B2 (ja)	2014-07-09
WO2009120697A3 (en)	2010-02-18
US20090246291A1 (en)	2009-10-01
MX2010010621A (es)	2011-04-05
RU2508116C2 (ru)	2014-02-27
PT2268292T (pt)	2018-02-19
CA2719766C (en)	2017-10-31
WO2009120697A4 (en)	2010-04-15
CA2719766A1 (en)	2009-10-01
EP2268292B1 (en)	2017-12-27

Legal Events

Date	Code	Title	Description
2017-05-16	B25C	Requirement related to requested transfer of rights	Owner name: KOMIPHARM INTERNATIONAL CO., LTD. (KR)
2017-06-13	B25L	Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled	Owner name: KOMIPHARM INTERNATIONAL CO., LTD. (KR)
2017-06-27	B25A	Requested transfer of rights approved	Owner name: KOMINOX, INC (KY)
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-07-02	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-10-15	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-02-11	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-06-02	B09B	Patent application refused [chapter 9.2 patent gazette]
2020-08-18	B12B	Appeal against refusal [chapter 12.2 patent gazette]

Publication	Publication Date	Title
BRPI0919238A2 (pt)	2019-09-24	métodos e composições para o tratamento de câncer
BRPI0909164A2 (pt)	2016-06-21	método e composições para o tratamento de câncer
BRPI1007972A2 (pt)	2016-09-13	composições de combinação e métodos para o tratamento de câncer
BRPI0811589A2 (pt)	2014-10-29	Composição farmacêutica e método para tratar câncer
BRPI0908854A2 (pt)	2019-09-24	composições e métodos para o tratamento de tumor de origem hematopoética
BRPI1008566A2 (pt)	2017-06-06	métodos e composições para o diagnóstico e tratamento de câncer
BRPI0813725A2 (pt)	2014-12-30	Métodos e composições para tratamento de doenças
BRPI0921321A2 (pt)	2018-10-16	métodos para o tratamento de indwcções e tumores
BRPI0810206A2 (pt)	2014-10-21	Método de tratar câncer
BRPI0922122A2 (pt)	2017-08-01	composições e métodos para tratamento de doença celíaca.
BR112012004979A2 (pt)	2015-09-08	composições para o tratamento de semente e métodos
BRPI1011325A2 (pt)	2016-03-15	composições e métodos para o tratamento de inflamação
PT2434891T (pt)	2020-10-23	Métodos para tratamento de cancro e afeções não neoplásicas
BRPI0807918A2 (pt)	2017-05-16	composições e método para preservação de tecido
BRPI0908635A2 (pt)	2015-10-13	composto, composição farmacêutica e método de tratamento de câncer
BRPI0822349A2 (pt)	2019-09-24	composições e métodos para tratar doenças lisossômicas
BRPI1010874A2 (pt)	2017-05-30	composição para o tratamento de câncer de próstata
BRPI1007600A2 (pt)	2019-09-24	composições e métodos para tratamento de doenças cardiovasculares
BRPI0921959A2 (pt)	2017-05-30	métodos e composições para remoção de tatuagem
BRPI0911112A2 (pt)	2015-10-06	composições e métodos para o tratamento do câncer de mama
PT2632452T (pt)	2019-01-10	Compostos e composições para o tratamento do cancro
BRPI0922884A2 (pt)	2018-11-06	compostos para tratamento de câncer
BRPI0908715A2 (pt)	2016-05-03	métodos para tratamento da psoríase
BRPI0909016A2 (pt)	2015-12-22	anticorpos úteis para o tratamento do câncer
BRPI1007929A2 (pt)	2015-09-01	"métodos e composições para o tratamento de neovascularização".